These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 32564281)
1. Nephropathic cystinosis: an update on genetic conditioning. Topaloglu R Pediatr Nephrol; 2021 Jun; 36(6):1347-1352. PubMed ID: 32564281 [TBL] [Abstract][Full Text] [Related]
2. CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report. Papizh S; Serzhanova V; Filatova A; Skoblov M; Tabakov V; van den Heuvel L; Levtchenko E; Prikhodina L BMC Nephrol; 2019 Oct; 20(1):400. PubMed ID: 31672123 [TBL] [Abstract][Full Text] [Related]
3. Cystinosin-deficient rats recapitulate the phenotype of nephropathic cystinosis. Hollywood JA; Kallingappa PK; Cheung PY; Martis RM; Sreebhavan S; 'Atiola RD; Chatterjee A; Buckels EJ; Matthews BG; Lewis PM; Davidson AJ Am J Physiol Renal Physiol; 2022 Aug; 323(2):F156-F170. PubMed ID: 35695380 [TBL] [Abstract][Full Text] [Related]
4. Effects of long-term cysteamine treatment in patients with cystinosis. Ariceta G; Giordano V; Santos F Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317 [TBL] [Abstract][Full Text] [Related]
5. [From gene to disease: cystinosis]. Levtchenko EN; Wilmer M; de Graaf-Hess AC; van den Heuvel LP; Blom H; Monnens LA Ned Tijdschr Geneeskd; 2004 Mar; 148(10):476-8. PubMed ID: 15042893 [TBL] [Abstract][Full Text] [Related]
6. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN; Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776 [TBL] [Abstract][Full Text] [Related]
7. The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis. Brasell EJ; Chu L; El Kares R; Seo JH; Loesch R; Iglesias DM; Goodyer P Pediatr Nephrol; 2019 May; 34(5):873-881. PubMed ID: 30413946 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report. Higashi S; Matsunoshita N; Otani M; Tokuhiro E; Nozu K; Ito S BMC Nephrol; 2017 Sep; 18(1):300. PubMed ID: 28950840 [TBL] [Abstract][Full Text] [Related]
9. Cystinosis: a review. Elmonem MA; Veys KR; Soliman NA; van Dyck M; van den Heuvel LP; Levtchenko E Orphanet J Rare Dis; 2016 Apr; 11():47. PubMed ID: 27102039 [TBL] [Abstract][Full Text] [Related]
10. CTNS mutations in patients with cystinosis. Anikster Y; Shotelersuk V; Gahl WA Hum Mutat; 1999; 14(6):454-8. PubMed ID: 10571941 [TBL] [Abstract][Full Text] [Related]
11. Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis. Hollywood JA; Przepiorski A; D'Souza RF; Sreebhavan S; Wolvetang EJ; Harrison PT; Davidson AJ; Holm TM J Am Soc Nephrol; 2020 May; 31(5):962-982. PubMed ID: 32198276 [TBL] [Abstract][Full Text] [Related]
13. An Indian boy with nephropathic cystinosis: a case report and molecular analysis of CTNS mutation. Tang S; Danda S; Zoleikhaeian M; Simon M; Huang T Genet Test Mol Biomarkers; 2009 Aug; 13(4):435-8. PubMed ID: 19580442 [TBL] [Abstract][Full Text] [Related]